جست‌وجوی استاد و پژوهشگر

Deanna Santerمشاهده پروفایل

استادیار

• Interferon biology
• Antiviral immunity
• Immunoregulation
• +۳ مورد دیگر

Dr. Deanna Santer is an Assistant Professor in the Department of Immunology at the Max Rady College of Medicine, University of Manitoba, and holds the GSK Endowed Research Chair in Immunobiology of Infectious Diseases. Her research focuses on interferon biology, particularly type I vs. type III interferons' roles in antiviral immunity and inflammation. She collaborates on clinical trials investigating interferon-lambda treatments for COVID-19 and studies the role of interferons in inflammatory bowel disease (IBD) and gut health. Affiliations: GSK Endowed Research Chair, Children's Hospital Research Institute of Manitoba (CHRIM) Educational Background: B.Sc. (Hons) in Immunology and Infection (University of Alberta, 2005), Ph.D. in Immunology (University of Washington, 2010), Postdoc under Dr. Michael Houghton (University of Alberta, 2017) Her research themes include antiviral immunity, chronic inflammation, and immune cell biology. Key projects involve analyzing how dietary fibers and microbiota influence IBD through interferon-lambda pathways, and evaluating interferon-based therapies for viral infections. Dr. Santer has secured over $9.6M in federal grants, including CIHR operating grants for COVID-19 research and IBD studies. Recognition: Recipient of the Ray Owen Young Investigator Award (2008), CIHR postdoctoral fellowship, and multiple grants recognizing her contributions to immunology and infectious disease research. Labs & Teams: The Santer Lab, established in 2020, investigates gut immunity and interferon signaling in IBD. It collaborates with institutions like the University of Alberta and University Health Network. The lab is actively recruiting Ph.D. students for 2026.

Sizheng Zhaoمشاهده پروفایل

استاد بالینی

• Mendelian Randomization Analysis
• Rheumatoid Arthritis
• Psoriatic Arthritis
• +۵ مورد دیگر

Sizheng Zhao is a Clinical Professor at the Division of Musculoskeletal & Dermatological Sciences, University of Manchester. He holds the Dean’s Prize and specializes in clinical research focusing on rheumatological disorders, drug safety, and genetic epidemiology. His work contributes to UN Sustainable Development Goals related to health and well-being. Research interests include Mendelian Randomization studies, inflammatory arthritis (rheumatoid/psoriatic), diabetes comorbidities, and cardiovascular outcomes associated with biologic therapies. He has published over 184 peer-reviewed articles and led studies on drug efficacy/safety (e.g., JAK inhibitors, SGLT2 inhibitors) and real-world data platforms like TriNetX. Key achievements include receiving the Apothecaries Prize (2022) and Turnberg Cup (2022). He collaborates internationally on projects involving axial spondyloarthritis, bimekizumab treatment, and cardiovascular risk modeling in arthritis patients. His work has been featured in media coverage about osteoporosis treatments, vitamin D’s role in psoriasis, and cardiovascular risk reduction strategies. Notable datasets include genetic instruments for BMI analysis and drug safety comparisons. Zhao’s research emphasizes translational medicine, bridging genetic insights with clinical practice to improve treatment outcomes for chronic inflammatory diseases.

• Patient and Public Involvement (PPI) in Healthcare
• Fatigue Management (Cancer-Related, Chronic Fatigue Syndrome, ME/CFS)
• Work Rehabilitation for Long-Term Conditions
• +۳ مورد دیگر

Dr. Anne Johnson is an Associate Professor for Knowledge Exchange and Patient/Public Involvement in Learning and Teaching at the University of the West of England (UWE) within the College of Health, Science and Society. She also serves as a Consultant Occupational Therapist and Joint Clinical Lead of the Bath Centre for Fatigue Services, alongside roles as a Macmillan Professional and Senior Lecturer at UWE. Her expertise spans fatigue management (including ME/CFS, cancer-related fatigue, and post-COVID fatigue), occupational science, and leadership in healthcare innovation. Dr. Johnson holds a PhD from UWE (2017) on men's experiences of CFS/ME, an MA, and professional qualifications including Dip COT (Occupational Therapy), RNLD (Neurological Rehabilitation), and FETC (Executive Coaching). She actively participates in national committees like the Royal College of Occupational Therapists and Macmillan Cancer Support's AHP Expert Advisory Group. Her research focuses on user-centered healthcare systems, with special interests in: fatigue management strategies, work rehabilitation for chronic conditions, and integrating patient/public involvement into clinical practice and education. She has led initiatives to improve service redesign, interprofessional collaboration, and mentoring frameworks in academic and clinical settings. Collaborations include the Personalised Care Institute and Macmillan Cancer Support. Her publications highlight themes like reverse mentoring for academics, PPI in lab programs, and interdisciplinary cancer fatigue management. She has also contributed to policy work with the Department of Health and Work and Pensions. Dr. Johnson’s leadership extends to the Bath Centre for Fatigue Services, where she operationalizes evidence-based practices. Her future work emphasizes scaling patient-informed solutions and advancing occupational science applications in chronic illness management.

• Localized Scleroderma
• Autoantibodies
• Systemic Lupus Erythematosus
• +۵ مورد دیگر

Christian Damsgaard Jørgensen is an External Associate Professor at the Department of Mathematics and Computer Science, University of Southern Denmark. He holds a B.Sc. in Computer Science and an M.Sc. in Applied Mathematics. His interdisciplinary research bridges computational methods with biomedical applications. B.Sc.: Computer Science M.Sc.: Applied Mathematics Active in immunology and molecular medicine, his work focuses on autoimmune diseases like localized scleroderma and systemic lupus erythematosus, with a particular emphasis on nucleic acid antigens and autoantibody profiling. He also contributes to biochemical assay development for nucleic acid detection. Recent research trends include exploring the role of imprinted genes in metabolic disorders (e.g., Dlk1 in obesity/insulin resistance) and advancing tissue-engineered vascular grafts through meta-analytical techniques.

• Psycho-Oncology
• Psychosocial Oncology
• Health Services Research
• +۷ مورد دیگر

Dr. Arwa Aburizik is a Clinical Associate Professor in the Department of Internal Medicine-Hematology, Oncology, and Blood and Marrow Transplantation at the University of Iowa Carver College of Medicine. She is also the Director of the Psychosocial Oncology Program at University of Iowa Health Care, where she integrates mental health services into comprehensive cancer care. Her educational background includes an MD from Jordan University of Science and Technology and an MS in Clinical Investigations from the University of Iowa College of Public Health. Her training encompasses dual residency in Medicine and Psychiatry and a fellowship in VA Quality Scholars (Advanced Fellowship in Health Services Research). Dr. Aburizik's research focuses on psychosocial oncology, with emphasis on disparities in mental health care access, particularly among Black women and AYA (Adolescent and Young Adult) cancer patients. She investigates integrated collaborative care models to improve depression and anxiety treatment in cancer populations. Her work also explores ethical challenges in managing cancer patients with comorbid mental illness. Her recent publications reveal a strong trend toward health services research in psycho-oncology, focusing on referral patterns, access barriers, and effectiveness of integrated care models. The body of work consistently addresses equity, patient-centered care, and system-level interventions to enhance psychosocial support in oncology settings. Ethical management of patients with cancer and mental illness (2017) Mistaken identity: normotensive scleroderma renal crisis (2014) A pilot randomized controlled trial of a depression and disease management program delivered by phone (2013) Dr. Aburizik is actively engaged in clinical research and program leadership. As Director of the Psychosocial Oncology Program, she leads initiatives to expand access to mental health services for cancer patients. Her work bridges psychiatry and internal medicine, contributing to both clinical practice and health policy. She has not listed any formal advisees or mentoring roles in the provided text, nor are specific grants or awards mentioned. Her research is supported through institutional affiliations such as the Holden Comprehensive Cancer Center. She is affiliated with the Holden Comprehensive Cancer Center and contributes to interdisciplinary efforts in cancer care. Her work involves collaboration across psychiatry, oncology, and public health to develop and evaluate behavioral health integration strategies. Future directions likely include expanding telehealth interventions, addressing systemic biases in referral practices, and enhancing training for clinicians in psychosocial oncology.

• Immunology
• Oncology
• Amyloidosis
• +۳ مورد دیگر

Dr. Bart Jan Kroesen is an Associate Professor at the Faculty of Medical Sciences, University of Groningen. His research focuses on immunology, oncology, and amyloidosis, with a particular interest in biomarker development, T-cell biology, and translational immunology. He contributes to clinical trials involving cancer vaccines and immunotherapy strategies. His work bridges basic science and clinical applications, addressing challenges in diagnostics and treatment for conditions like Hodgkin lymphoma, systemic amyloidosis, and COPD. Key research areas include: Biomarkers for disease progression and treatment response Mechanisms of immune checkpoint inhibitors in cancer therapy Diagnostic methods for systemic amyloidosis subtypes HLA antibody interactions in organ transplantation Neurofilament markers in neurodegenerative disorders He maintains consultancy roles with PRA International and QPS, and his recent studies highlight interdisciplinary collaborations in immunology, oncology, and cardiology. His publications reflect a focus on precision medicine and innovative diagnostic tools.

• Dermatology
• Autoimmune Skin Diseases
• Cutaneous Lupus Erythematosus
• +۶ مورد دیگر

Sarika Ramachandran, MD, is Associate Professor of Dermatology at Yale School of Medicine and serves as Vice Chair of Collaborative Excellence and Faculty Engagement. She directs Yale Medicine Dermatology in Branford and co-directs the Autoimmune Skin Disease Program, with focused clinical and research efforts in cutaneous lupus, scleroderma, and morphea. Education & Training MD – SUNY Stony Brook School of Medicine, 2007 BS – SUNY Stony Brook, 2003 Research Interests Dr Ramachandran’s research integrates translational immunodermatology with health-equity initiatives. Her laboratory interrogates stromal–immune crosstalk in cutaneous lupus using single-cell transcriptomics, investigates patient-centered outcomes in autoimmune dermatoses, and evaluates racial representation in medical education materials. Additional projects explore novel vascular-targeted therapies for lupus vasculitis and the epidemiology of overlapping autoimmune skin diseases. Publication Trends Since 2020 she has published 49 peer-reviewed works that cluster around four themes: (1) mechanistic studies of cutaneous lupus and interferon signaling, (2) clinical characterization of rare autoimmune dermatoses, (3) health-services research on consultation patterns and patient education, and (4) equity-focused analyses of dermatology curricula and patient materials. Scientific Awards & Honors Featured in Connecticut Magazine “Top Doctors” list, 2024 Principal Investigator on Yale SPORE in Skin Cancer pilot projects Teaching & Mentorship She mentors residents and fellows through the Yale Investigative Dermatology Training Program and the Advanced Dermatologic Surgery Fellowship, leads the curriculum for advancing racial equity (CARE) initiative, and supervises clinical trials on morphea and lupus therapeutics. Laboratories & Programs Dr Ramachandran co-directs the Yale Scleroderma Program and collaborates closely with the Yale Rheumatology-Dermatology combined clinic, providing integrated care and joint clinical trials for complex autoimmune skin disease patients.

• Dermatopathology
• Fibrosis
• Alopecia
• +۴ مورد دیگر

Shawn Cowper, MD, is an Associate Professor of Dermatology and Pathology at Yale School of Medicine , specializing in dermatopathology and alopecia research. He discovered Nephrogenic Systemic Fibrosis (NSF) linked to gadolinium-based contrast agents, leading to FDA regulatory changes. Education MD from Michigan State University (1990) BS in English Literature and Cellular/Molecular Biology from University of Michigan (1986) Residency at University of South Florida and Henry Ford Hospital Fellowship at University of California, San Francisco (2001) His research focuses on fibrosing disorders , particularly NSF and systemic sclerosis, with an emphasis on AI applications in skin outcomes. He co-authored a textbook on hair pathology and developed the Pathmax web-based pathology resource. Recent publications address skin manifestations in kidney disease, AI-driven systemic sclerosis trials, and environmental diagnostic mimics. Key themes include dermatopathology , fibrosis mechanisms , and vaccine-related dermatoses . Scientific Awards Medal for Service Above and Beyond (2018) Distinguished Dermatopathologist (2017) Annual Saul Farber Lecturer (2008) Certificate of Appreciation (2007) Dr. Cowper actively teaches dermatopathology to residents and fellows, serves as Chair of the American Society of Dermatopathology's Virtual Slide Library, and maintains the International NSF Registry at Yale. He collaborates with multidisciplinary teams in the Yale SPORE in Skin Cancer and Yale Fibrosis Symposium .

Valerie Horsleyمشاهده پروفایل

استاد

• Stem cell biology
• Dermatology
• Tissue regeneration
• +۷ مورد دیگر

Valerie Horsley, Ph.D. , is the Maxine F. Singer Associate Professor of Molecular, Cellular and Developmental Biology at Yale University and an Associate Professor (secondary) of Dermatology within the Yale School of Medicine. She is further affiliated with the Yale Cancer Center, Yale Stem Cell Center, BBS Program, Diabetes Research Center, and Obesity Research Working Group, and is a key member of the Yale SPORE in Skin Cancer (YSPORE). Education & Training B.S. in Biology, Furman University (1998) Ph.D. in Biochemistry, Cell & Developmental Biology, Emory University (2003) Damon Runyon Postdoctoral Fellowship, Rockefeller University, Elaine Fuchs Laboratory (2003–2008) Research Focus Dr. Horsley’s laboratory employs mouse genetics, single-cell genomics, advanced imaging, and functional genomics to dissect how adult epithelial stem cells interact with adipocytes, fibroblasts, immune cells, and the extracellular matrix to maintain tissue homeostasis, execute wound repair, and, when dysregulated, promote fibrosis or tumorigenesis. Central themes include: Stromal cell identity and plasticity in skin regeneration and cancer Mechanical regulation of cell fate and ECM remodeling Metabolic control (lipids, glutamine) of immune and stem-cell behavior Translational models of scleroderma, diabetic wounds, and scarless healing Publication Trends Between 2022 and 2025, the group has produced a steady stream of high-impact papers that integrate mechanistic mouse work with clinical translation. Topics range from intermittent-fasting effects on hair-follicle stem-cell survival to adipocyte-driven restraint of dermal fibrosis, illustrating a cohesive trajectory toward manipulating stromal-immune circuits for regenerative medicine. Scientific Honors Presidential Early Career Award for Scientists and Engineers (PECASE, 2012) Pew Scholar in the Biomedical Sciences (2011) Rosalind Franklin Young Investigator Award (2012) Montagna Lecture, Society for Investigative Dermatology (2018) Distinguished Alumni Award, Emory GDBBS (2019) Training & Mentorship Environment Hosts 4–6 postdoctoral fellows, 3–4 graduate students, and multiple undergraduates at any given time Weekly one-on-one meetings, annual goal-setting retreats, and peer-mentorship circles Alumni have secured faculty positions, post-doctoral fellowships, and industry R&D roles worldwide Lab Location & Collaboration The Horsley Lab is situated in Kline Biology Tower on Yale’s Science Hill, fostering daily interactions with geneticists, cell biologists, engineers, and clinician-scientists. Ongoing collaborations span Yale Dermatology, Biomedical Engineering, Immunobiology, and the Yale SPORE in Skin Cancer, ensuring that fundamental discoveries are rapidly translated toward therapies for fibrotic disease and chronic wounds.

• Dermatology
• Medical Dermatology
• Infectious Dermatology
• +۲ مورد دیگر

Dr. Jamie Zussman serves as a Clinical Associate Professor in Dermatology at the University of Utah School of Medicine. Board certified in Dermatology and Dermatopathology, she practices exclusively at the George E. Wahlen VA Medical Center, focusing on general dermatology, infectious conditions, medical dermatology, and skin cancer management. Her academic training includes an M.D. from UCLA's David Geffen School of Medicine, followed by dermatology residency and dermatopathology fellowship at the same institution. Additional training comprises an internal medicine internship at Cedars-Sinai Medical Center and undergraduate studies in Political Science at the University of Michigan. Medical Degree: David Geffen School of Medicine at UCLA Fellowship: Dermatopathology, David Geffen School of Medicine at UCLA Residency: Dermatology, David Geffen School of Medicine at UCLA Internship: Preliminary Internal Medicine, Cedars-Sinai Medical Center Undergraduate: B.A. in Political Science, University of Michigan Dr. Zussman's research concentrates on clinical dermatology with emphases on infectious diseases, inflammatory conditions, and skin cancer. Her work frequently addresses rare presentations, drug reactions, and diagnostic challenges in dermatopathology. Recent publications explore necrotizing dermatitis, Sweet syndrome variants, melanoma progression, and viral skin infections. Her publication record (2022-2024) demonstrates consistent contributions to dermatology literature, primarily through case reports and clinical studies. Key themes include infectious dermatology (particularly fungal and viral infections), adverse drug reactions, and histopathological analysis of skin conditions. This body of work highlights her expertise in complex diagnostic scenarios. No scientific awards are documented in the provided materials. Information regarding student advising, research grants, laboratory facilities, or collaborative teams is not included in the available sources.

Jungwha Leeمشاهده پروفایل

استاد

• Biostatistics
• Epidemiology
• Longitudinal Data Analysis
• +۷ مورد دیگر

Jungwha Lee is a Professor in the Department of Preventive Medicine (Biostatistics and Informatics) at Northwestern University Feinberg School of Medicine. Her research focuses on statistical methods in epidemiology, longitudinal data analysis, and risk prediction models for diverse study designs, including cohort, nested case-control, and registry data. Education includes: MPH from Seoul National University (2001) MS from University of Michigan (2003) PhD from University of Illinois at Chicago (2009) Her recent publications highlight trends in biostatistical modeling of sedentary behavior, arthritis research, and systemic sclerosis. Key areas include multilevel analysis of physical function loss, accelerometer-based metrics, and methodological advancements in risk prediction. Professional affiliations include: Institute for Augmented Intelligence in Medicine Institute for Public Health and Medicine (IPHAM) Northwestern University Clinical and Translational Sciences Institute (NUCATS) Leadership roles span the Korean International Statistical Society (Executive Director, 2021–2023) and American Statistical Association (SPAIG Academia Representative, 2018–2023).

Deborah Winterمشاهده پروفایل

دانشیار

• Immunology
• Rheumatology
• Transcriptomics
• +۴ مورد دیگر

Deborah Winter serves as Associate Professor of Medicine in the Division of Rheumatology at Northwestern University's Feinberg School of Medicine, holding the Solovy/Arthritis Research Society Research Professor title. Her work is deeply integrated with multiple research centers including the Center for Genetic Medicine, Center for Human Immunobiology, and the Northwestern University Clinical and Translational Sciences Institute. Dr. Winter's research program centers on immunological mechanisms in autoimmune diseases, with particular focus on macrophage and monocyte heterogeneity in rheumatoid arthritis, systemic sclerosis, and lupus. She employs cutting-edge single-cell transcriptomic approaches to dissect cellular dysregulation in synovial tissue, esophageal epithelium, and kidney development, revealing novel pathways for therapeutic intervention. Her work bridges basic science discoveries with clinical applications in precision medicine. Analysis of her 15 most recent publications (2023-2025) demonstrates consistent investigation of immune cell subsets across diverse disease contexts. Key themes include transcriptional regulation of stromal cells by TCF21, monocyte aging signatures in scleroderma, and macrophage heterogeneity in obstructive cholestasis and eosinophilic esophagitis. This body of work reveals fundamental insights into tissue-specific immune responses with direct implications for biomarker development and targeted therapies. As an active member of Northwestern's research ecosystem, Dr. Winter contributes to interdisciplinary collaborations advancing immunobiology and translational medicine, with recent work featured in high-impact studies on viral pneumonia mechanisms and chronic inflammation suppression.

Karin Würtz-Kozakمشاهده پروفایل

استاد

• Mechanobiology
• Regenerative Medicine
• Tissue Engineering
• +۴ مورد دیگر

Prof. Dr. Karin Würtz-Kozak is the Kate Gleason & Harvey J. Palmer Endowed Professor in the Department of Biomedical Engineering at Kate Gleason College of Engineering, Rochester Institute of Technology (RIT), with affiliate status in the Thomas H. Gosnell School of Life Sciences. She directs the Tissue Regeneration and Mechanobiology (TRAM) Laboratory, focusing on inflammation, fibrosis, and regenerative therapies for musculoskeletal, skin, and lung disorders. Education: Ph.D. in Human Biology, University of Ulm, Germany MBA in Leadership & Sustainability, University of Cumbria, UK M.S./B.S. in Pharmaceutical Sciences, University of Regensburg, Germany Research Interests: Her lab investigates molecular pathophysiology of degenerative diseases (e.g., intervertebral disc degeneration, scleroderma) using biomaterials, CRISPR genome editing, extracellular vesicles, and mechanobiology approaches. Key themes include anti-inflammatory biologics, TRP channel modulation, and 3D tissue models for drug testing and regeneration. Publication Trends: Recent work (2023–2025) emphasizes CRISPR-enhanced extracellular vesicles for disc regeneration, TRP channel roles in pain/fibrosis, plant-derived nanotherapeutics, and miRNA dysregulation in trauma-related bone disorders. Studies integrate molecular biology, advanced biomaterials, and preclinical models. Awards & Honors: Fellow, American Institute for Medical and Biological Engineering (AIMBE) Swiss National Science Foundation Professorship Award Advising & Grants: Mentors 6 PhD students in projects on gene editing, EV therapies, and mechanobiology. Secured >$8M in funding from NIH, NSF, DoD, and Eurospine, including: NIH R21AR081987 (CRISPR-engineered EVs for disc regeneration) DoD CDMRP SL20014 (TRPC6 inhibition for scleroderma) NSF FMSG 2229111 (Scalable EV biomanufacturing) Laboratory: Leads the TRAM Lab with competencies in primary cell culture, electrospinning, gene editing, and mechanotransduction assays. Collaborates with ETH Zurich, University of Syracuse, and industry partners.

• Sports Endocrinology
• Muscle Endocrinology
• Hormonal Doping
• +۶ مورد دیگر

Di Luigi Luigi serves as Full Professor at Università degli Studi di Roma Foro Italico within the Department of Human and Health Motor Sciences. He directs the Endocrine Research Laboratory, focusing on the intersection of endocrinology, sports science, and gender-specific physiology. His institutional roles include teaching in Bachelor's and Master's programs in Exercise Sciences. Research interests span multiple specialized domains: Neuroendocrine responses to physical stress Hormonal doping mechanisms and detection Gender differences in muscle metabolism and steroid production Exercise effects on postprandial metabolism Inflammatory cytokine regulation across menopausal status Phosphodiesterase inhibitor effects on fibrotic diseases His 2021 publications demonstrate strong translational focus, connecting basic science (in vitro muscle cell studies) with clinical applications (exercise interventions for diabetes, doping countermeasures). Key themes include gender-specific physiological responses and molecular mechanisms underlying exercise-endocrine interactions. Funding supports active research in endocrine-metabolic adaptations, with emphasis on practical applications in sports medicine and preventive healthcare. The laboratory maintains collaborations with multiple Italian universities for comprehensive investigation of endocrine responses to physical stressors. The Endocrine Research Laboratory provides specialized facilities for hormone analysis, cell culture studies, and metabolic monitoring, supporting both fundamental research and clinical applications in sports endocrinology.

Carrie L Richardsonمشاهده پروفایل

دانشیار

• Scleroderma
• Interstitial Lung Disease
• Myositis
• +۳ مورد دیگر

Carrie L Richardson, MD, MHS, serves as Associate Professor in the Department of Medicine at Northwestern University's Feinberg School of Medicine, where she co-directs the Northwestern Scleroderma Center. Affiliated with Northwestern Memorial Hospital, she specializes in scleroderma and myositis care while leading national research initiatives through the CONQUER collaborative network. Her academic credentials include: BA from Harvard University (2006) MD from Northwestern University (2012) MHSc from Johns Hopkins Bloomberg School of Public Health (2018) Internal Medicine Residency at McGaw Medical Center of Northwestern University (2015) Rheumatology Fellowship at Johns Hopkins University (2018) Dr. Richardson's research focuses on scleroderma pathogenesis and complications, particularly interstitial lung disease, calcinosis, and myositis. She employs clinical registry data and machine learning approaches to identify disease biomarkers and optimize treatment strategies, with emphasis on real-world therapeutic outcomes and patient-centered metrics. Her work bridges laboratory insights with clinical applications through the Northwestern Scleroderma Center's multidisciplinary framework. Recent 2025 publications demonstrate her dual focus on therapeutic innovation (nintedanib trials) and methodological advancement (machine learning for mortality prediction), while expanding diagnostic understanding of non-Raynaud presentations and validating patient-reported outcome tools for skin manifestations. Professional recognition includes: Resident Teaching Award, Northwestern University Department of Internal Medicine (2013) She currently leads two major clinical trials - the Northwestern Scleroderma Program Registry and CONQUER Registry - which collect longitudinal clinical data and biosamples to investigate disease progression, treatment responses, and genetic factors. These initiatives support future therapeutic development and personalized medicine approaches in scleroderma. As Executive Committee Member of CONQUER and Co-chair of ACR Abstract Sessions, she fosters national collaboration among scleroderma researchers while maintaining active roles in the American College of Rheumatology and American Medical Association.